Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Johnson & Johnson (JNJ) had Normalized Pre-Tax Income of $4.97B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$24.56B |
|
$5.12B |
|
$7.97B |
|
$16.60B |
|
$19.60B |
|
$4.97B |
|
-- |
|
$4.97B |
|
|
Normalized Pre-Tax Income |
$4.97B |
$5.12B |
|
$5.12B |
|
$5.12B |
|
$5.12B |
|
$4.99B |
|
-- |
|
-- |
|
2.44B |
|
-- |
|
$2.10 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|